Table 1.
Baseline characteristics.
| Total n = 13,896 | Soap-based (reference) n = 4708 | Disinfection n = 4535 | Probiotic n = 4653 | |
|---|---|---|---|---|
| Basic demographics | ||||
| Total length of stay, median (IQR) | 6 (4–10) | 6 (4–10) | 7 (4–11) | 6 (4–10) |
| Exposure days, median (IQR) | 5 (4–8) | 5 (4–8) | 5 (4–8) | 5 (4–8) |
| Age, median (IQR) | 61 (47–74) | 62 (49–74) | 61 (46–73) | 60 (47–74) |
| Male gender | 53% (n = 7368) | 53% (n = 2504) | 53% (n = 2418) | 53% (n = 2446) |
| Comorbidities | ||||
| Heart disease | 9% (n = 1177) | 9% (n = 417) | 8% (n = 379) | 8% (n = 381) |
| Diabetes | 16% (n = 2267) | 16% (n = 760) | 16% (n = 740) | 17% (n = 767) |
| Petptic ulcer | 1% (n = 108) | 1% (n = 38) | 1% (n = 37) | 1% (n = 33) |
| Liver disease | 5% (n = 742) | 5% (n = 250) | 5% (n = 240) | 5% (n = 252) |
| Neurological disease | 4% (n = 520) | 4% (n = 169) | 4% (n = 196) | 3% (n = 155) |
| Cancer | 19% (n = 2633) | 20% (n = 928) | 19% (n = 852) | 18% (n = 853) |
| Rheuma | 8% (n = 1154) | 9% (n = 420) | 8% (n = 378) | 8% (n = 356) |
| AIDS/HIV | <1% (n = 37) | <1% (n = 17) | <1% (n = 11) | <1% (n = 9) |
| Lung disease | 9% (n = 1198) | 9% (n = 402) | 9% (n = 402) | 9% (n = 394) |
| Renal disease | 20% (n = 2773) | 18% (n = 865) | 20% (n = 912) | 21% (n = 996) |
| Leukemia | <1% (n = 35) | <1% (n = 10) | <1% (n = 10) | <1% (n = 15) |
| Charlson Comorbidity Index, median (IQR) | 3 (1–5) | 3 (1–5) | 3 (1–5) | 3 (1–5) |
| All cause mortality | <1% (n = 116) | <1% (n = 29) | <1% (n = 45) | <1% (n = 42) |
Data are presented as % (n) unless stated otherwise.
IQR, interquartile range.